Crinetics Pharmaceuticals (CRNX) Preferred Shares Issued (2017 - 2018)

Crinetics Pharmaceuticals (CRNX) recorded quarterly Preferred Shares Issued of $9000.0 in Q4 2018, up 103.85% quarter-over-quarter from -$234000.0 in Q2 2018, and down 99.92% on a YoY basis from $12.0 million in Q4 2017.

Crinetics Pharmaceuticals (CRNX) Preferred Shares Issued (2017 - 2018) Analysis & Trends

Crinetics Pharmaceuticals' Preferred Shares Issued history runs 2 years deep, the most recent figure standing at $9000.0 for Q4 2018.

  • In Q4 2018, Preferred Shares Issued fell 99.92% year-over-year to $9000.0; the TTM figure through Dec 2018 stood at $63.3 million (changed N/A YoY), while the FY2018 annual figure was $63.3 million, up 427.29% from the prior year.
  • Preferred Shares Issued was $9000.0 for Q4 2018 at Crinetics Pharmaceuticals, up from -$234000.0 in the prior quarter.
  • In the past five years, Preferred Shares Issued ranged from a high of $63.5 million in Q1 2018 to a low of -$234000.0 in Q2 2018.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Shares Issued (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 Crinetics Pharmaceuticals 3.75 Bn 3.75 Bn 10.53 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2018 9,000.00
Dec 31, 2018 9,000.00
Jun 30, 2018 -234,000.00
Jun 30, 2018 -234,000.00
Mar 31, 2018 63.50 Mn
Mar 31, 2018 63.50 Mn
Dec 31, 2017 12.00 Mn
Dec 31, 2017 12.00 Mn